Glueless, Sutureless Pterygium Excision using Biovance

In this video, Dr. Marguerite McDonald, Clinical Professor of Ophthalmology at NYU and Tulane, shares results from a recently published clinical study using Biovance® 3L Ocular for pterygium surgery and the outcomes are hard to ignore. Across 34 eyes in 33 patients, surgeons performed a glueless, sutureless approach with no conjunctival autograft. The procedure was faster, patients were remarkably comfortable post-op, required less steroid burden, and most notably, there were zero recurrences with an average follow-up of over 13 months. Key findings: 🎯0% recurrance rate 🎯No reported Complications As Dr. McDonald puts it: lower costs, increased efficiency, improved patient comfort, and excellent long-term results are a true win-win. 🎥 Watch for a clear, data-driven breakdown of how thoughtful surgical innovation can meaningfully improve outcomes for both surgeons and patients. References: McDonald, M. A Retrospective Review of Glueless, Sutureless Pterygium Excision Using Biovance Triple-Layer Decellularized Amniotic Basement Membrane Tissue. Ophthalmol Ther (2026). https://doi.org/10.1007/s40123-026-01311-6